If you are having surgery or a procedure involving anaesthesia, include your GLP-1 medicine in the preparation discussion. Tell the relevant team early, including when it was prescribed for weight management rather than diabetes. A clear, agreed plan is more useful than a universal stopping rule found online.
Health information for general guidance. This content provides general information. It does not replace medical advice, examination, diagnosis or treatment, or individual nutrition advice. Discuss medication decisions with your treating clinician; do not change treatment based on this page. Seek medical help for acute or severe symptoms.
Why anaesthesia makes this relevant
During general anaesthesia or deep sedation, the reflexes that protect your airway are reduced. Stomach contents entering the airway are called aspiration. GLP-1 medicines can contribute to material remaining in the stomach, which prompted the EMA to require relevant warnings.
This does not mean that you are expected to have a complication. It means the information belongs in the safety assessment. A procedure such as endoscopy may also be relevant when this level of sedation is planned. Ask what type of anaesthesia or sedation you will receive.
The information to bring
Write down the brand, active ingredient, formulation and your current prescribed treatment. Record when you actually last used the medicine and whether treatment recently started or changed. These are details for the professionals, not instructions to alter anything yourself.
Mention nausea, vomiting, fullness, abdominal pain, constipation and any known stomach-emptying disorder. A complete medicines list and details of diabetes help the team consider your overall care. A photograph of the packaging can prevent confusion between similar names or products.
Why one stopping rule does not fit everyone
The procedure, anaesthetic technique, symptoms and condition being treated all influence the decision. The 2024 guidance from several professional societies describes individual assessment; continuing treatment may be possible for people at lower risk. This is not a personal clearance to continue.
Interrupting treatment can also have consequences, including changes in blood glucose control. If two services give different instructions, ask them to coordinate and provide one clear written answer. Do not try to decide which instruction sounds safer on your own.
Clarify food and drink instructions
Follow the fasting instructions from your own facility. Meeting a standard fasting period does not automatically settle every safety question when stomach emptying is delayed. Your team may consider additional measures based on your situation and the resources available.
Do not extend fasting yourself or start a special liquid diet because a general article mentions it. Ask exactly what you may eat or drink and when, and which other medicines to take. Keep a contact number for questions that the written instructions do not answer.
On the day and after the procedure
Remind the admitting team about the medicine. Report new symptoms and any departure from the agreed plan honestly, even if you worry about postponement. Accurate information supports a safe decision; it should not be treated as a reason for blame.
Before discharge, clarify who is responsible for further treatment and any restart that may be needed. Eating, drinking and other medicines may change after surgery. If emergency surgery is needed, do not delay seeking medical help: inform the team as soon as possible.
Your next step
- Give the exact product name when arranging the procedure.
- Request one coordinated written plan for medicines and fasting.
- Find out whom to contact about new symptoms or conflicting instructions.
Common questions
Is telling my usual doctor enough?
Also notify the service responsible for the procedure and anaesthesia. Do not assume every professional can see the same up-to-date medicines list.
Does GLP-1 treatment mean surgery must be postponed?
No. The clinical team decides whether changes are needed after assessing your individual circumstances. Using the medicine does not automatically mean cancellation.
Sources & further reading
- EMA: GLP-1 medicines and anaesthesia, July 2024
- Multisociety guidance: GLP-1 medicines around procedures, 2024
- EMA: Wegovy – EPAR und Produktinformation
- EMA: Mounjaro – EPAR und Produktinformation
Sources checked:





Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact